SLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
SELLAS Life Sciences Group, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$10.49+0.51 (+5.11%)
Close on Oct 19, 2026
- Market cap
- $1.98B
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Nov 8, 2019 | 1-for-50 reverse | Earlier per-share figures multiplied by 50 |
| Nov 7, 2019 | 1-for-50 reverse | Earlier per-share figures multiplied by 50 |
| Jan 2, 2018 | 1-for-30 reverse | Earlier per-share figures multiplied by 30 |
| Mar 15, 2017(first seen in filings) | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |
| Nov 14, 2016 | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |